Extended lymphadenectomy to increase perioperative risks in Muscle-Invasive Bladder Cancer

Yüksel Ürün posted on X:

“Extended lymphadenectomy did not improve survival but increased perioperative risks in Muscle-Invasive Bladder Cancer.

• 5-year disease-free survival: Extended 56% vs Standard 60%
• Overall survival: E 59% vs S 63%
• Mortality within 90 days: Extended 7%, Standard 2%.

Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer

Authors: Seth P. Lerner, Catherine Tangen, Robert S. Svatek, Siamak Daneshmand, Kamal S. Pohar, Eila Skinner, Anne Schuckman, Arthur I. Sagalowsky, Norm D. Smith, Ashish M. Kamat, Wassim Kassouf, Melissa Plets, Rick Bangs, Theresa M. Koppie,  Ajjai Alva, Francisco G. La Rosa, Sumanta K. Pal,  Adam S. Kibel, Daniel J. Canter, Ian M. Thompson.”

Source: Yüksel Ürün/X

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.